Blog2024-07-01T14:28:28-05:00

Sleep Medicine Weekly Insider – September 4, 2021

The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. FDA authorizes Philips repair plan This week Philips announced that it has received FDA [...]

September 4th, 2021|Weekly Insider|

FDA authorizes Philips PAP device repair program

On Sept. 1, Philips announced that it has received authorization from the Food and Drug Administration to “rework” the recalled first-generation DreamStation devices by replacing the sound abatement foam with a new material. Philips anticipates that the repair program [...]

September 2nd, 2021|Featured, Industry|

Sleep Medicine Weekly Insider – August 28, 2021

The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. New MSLT and MWT protocols AASM has published updates to the recommended protocols for [...]

August 28th, 2021|Weekly Insider|

Sleep Medicine Weekly Insider – August 21, 2021

The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. Philips recall: Temporary PAP devices A July 16 FAQ posted by the DME MACs [...]

August 21st, 2021|Weekly Insider|

Sleep Medicine Weekly Insider – August 14, 2021

The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. Philips PAP recall: Bacteria filters Philips has posted supplemental information about bacteria filters, stating [...]

August 14th, 2021|Weekly Insider|

Represent the sleep specialty within the AMA

The AASM is up for a five-year review of its representation in the American Medical Association’s House of Delegates. Participation enables the AASM to represent the sleep specialty in two key committees overseeing practice and reimbursement issues: The AMA/Specialty [...]

August 13th, 2021|Advocacy|

Vote on 2021 proposed bylaws revisions

Dear AASM Member: The AASM Board of Directors periodically reviews governance documents as part of its general oversight of the organization. During a recent review of the bylaws, the AASM Board of Directors identified and recommended several changes that [...]

August 10th, 2021|Thought Leaders|

Sleep Medicine Weekly Insider – August 7, 2021

The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. Optimal Medicare NIV coverage criteria CHEST published reports from a technical expert panel involving [...]

August 7th, 2021|Weekly Insider|

Read the summer 2021 issue of Montage

Welcome to the latest edition of the AASM member magazine, Montage. In this issue, we highlight the AASM’s new clinical data registry, Sleep CDR. We also discuss the AASM-led response to a government report on the effectiveness of [...]

August 5th, 2021|Montage|

AASM Organizes Effort to Defend CPAP

By Jennifer Gibson, AASM Communications Manager A government-sponsored draft report on the effectiveness of continuous positive airway pressure (CPAP) therapy sent shockwaves through the sleep medicine community and prompted the American Academy of Sleep Medicine (AASM) to organize a [...]

August 5th, 2021|Montage|

August is AASM Member Appreciation Month

Throughout the past year, healthcare professionals have been on the frontline and our members have worked tirelessly to provide care and support to those in need. Starting Monday, August 2, the AASM will celebrate Member Appreciation Month to say [...]

August 1st, 2021|Featured, Membership|

Sleep Medicine Weekly Insider – July 31, 2021

The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. FAQs from FDA about Philips recall The FDA has posted responses to several patient-centered [...]

July 31st, 2021|Weekly Insider|

FDA grants breakthrough designation to Takeda narcolepsy drug

On July 28, 2021, Takeda Pharmaceutical Company announced the FDA granted Breakthrough Therapy designation to TAK-994, which may provide a future treatment option targeting the orexin deficiency underlying narcolepsy type 1. About TAK-994 TAK-994 is a Phase 2 investigational [...]

July 29th, 2021|Industry|

Sleep Medicine Weekly Insider – July 24, 2021

The American Academy of Sleep Medicine Weekly Insider keeps members informed about current AASM initiatives and the latest developments in the field of sleep medicine. From AASM President Dr. Raman Malhotra The voluntary PAP device recall by Philips has [...]

July 24th, 2021|Weekly Insider|
Go to Top